Prevention and treatment of cystitis during menopause: efficacy of a nutraceutical containing D-mannose, inulin, cranberry, bearberry, Olea europaea, Orthosiphon and Lactobacillus acidophilus
G Mainini, Mario Passaro, Antonio Schiattarella, Pasquale De Franciscis, Mariano Catello Di Donna, Gennaro Trezza
Abstract
AIM OF THE STUDY: , in preventing recurrent urinary tract infections (UTIs) in menopausal women. MATERIAL AND METHODS: This was a prospective cohort study of menopausal women recruited with a history of recurrent UTIs in the previous twelve months and who intended to treat their bladder problem without the use of antibiotics and/or anti-inflammatories. Women were proposed the use of an oral nutraceutical compound. The drug was taken for ten days, every month. Women were assigned to two parallel cohorts: patients using (group 1) or not using (group 2) this nutraceutical compound. The primary objective of the study was to evaluate the number of women with less than two infective episodes in the 6-month follow-up and less than three episodes in the 12-month follow-up. The secondary endpoints were to evaluate the reduction of related symptoms at 12-month follow-up, according to the Visual Analog Scale (VAS). RESULTS: < 0.05) in group 1, as shown by the reduction in the VAS scale value. CONCLUSIONS: SGL 11 per os represents a useful therapy for recurrent UTIs in women wanting a natural approach.